Pro PG receives S19A RoActemra tocilizumab 162mg/0.9mL PFS and PENS

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporary basis:

RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled syringe (Roche Germany)

RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled pen (Roche Germany)

These products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 28 February 2022

Please contact us for more information